Literature DB >> 29462324

Endometriosis induces gut microbiota alterations in mice.

Ming Yuan1, Dong Li2, Zhe Zhang3, Huihui Sun1, Min An1, Guoyun Wang1.   

Abstract

STUDY QUESTION: What happens to the gut microbiota during development of murine endometriosis? SUMMARY ANSWER: Mice with the persistence of endometrial lesions for 42 days develop a distinct composition of gut microbiota. WHAT IS KNOWN ALREADY: Disorders in the immune system play fundamental roles in changing the intestinal microbiota. No study has used high-throughput DNA sequencing to show how endometriosis changes the gut microbiota, although endometriosis is accompanied by abnormal cytokine expression and immune cell dysfunction. STUDY DESIGN, SIZE, DURATION: This study includes a prospective and randomized experiment on an animal endometriosis model induced via the intraperitoneal injection of endometrial tissues. PARTICIPANTS/MATERIALS, SETTING,
METHODS: The mice were divided into endometriosis and mock groups and were sacrificed at four different time points for model confirmation and fecal sample collection. To detect gut microbiota, 16S ribosomal-RNA gene sequencing was performed. Alpha diversity was used to analyze the complexity and species diversity of the samples through six indices. Beta diversity analysis was utilized to evaluate the differences in species complexity. Principal coordinate analysis and unweighted pair-group method with arithmetic means clustering were performed to determine the clustering features. The microbial features differentiating the fecal microbiota were characterized by linear discriminant analysis effect size method. MAIN RESULTS AND THE ROLE OF CHANCE: The endometriosis and mock mice shared similar diversity and richness of gut microbiota. However, different compositions of gut microbiota were detected 42 days after the modeling. Among the discriminative concrete features, the Firmicutes/Bacteroidetes ratio was elevated in mice with endometriosis, indicating that endometriosis may induce dysbiosis. Bifidobacterium, which is known as a commonly used probiotic, was also increased in mice with endometriosis. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: More control groups should be further studied to clarify the specificity of the dysbiosis induced by endometriosis. This study was performed only on mice. Thus, additional data acquired from patients with endometriosis are needed in future research. We only detected the changes of gut microbiota at 42 days after the modeling, while the long-term effect of endometriosis on gut microbiota remains poorly understood. Moreover, we only revealed a single effect of endometriosis on gut microbiota. WIDER IMPLICATIONS OF THE
FINDINGS: This study provided the first comprehensive data on the association of endometriosis and gut microbiota from high-throughput sequencing technology. The gut microbiota changed with the development of endometriosis in a murine model. The communication between the host and the gut microbiota is bidirectional, and further studies should be performed to clarify their relationship. STUDY FUNDING/COMPETING INTEREST(S): This research was supported by Grant (81571417) from the National Science Foundation of China and Grant (2015GSF118092) from the Technology Development Plan of Shandong Province. The authors report no conflict of interest.

Entities:  

Mesh:

Year:  2018        PMID: 29462324     DOI: 10.1093/humrep/dex372

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  32 in total

1.  Seeing red: diet and endometriosis risk.

Authors:  Rosalia C M Simmen; Angela S Kelley
Journal:  Ann Transl Med       Date:  2018-12

2.  Antibiotic therapy with metronidazole reduces endometriosis disease progression in mice: a potential role for gut microbiota.

Authors:  Sangappa B Chadchan; Meng Cheng; Lindsay A Parnell; Yin Yin; Andrew Schriefer; Indira U Mysorekar; Ramakrishna Kommagani
Journal:  Hum Reprod       Date:  2019-06-04       Impact factor: 6.918

3.  Fisetin regulates gut microbiota to decrease CCR9+/CXCR3+/CD4+ T-lymphocyte count and IL-12 secretion to alleviate premature ovarian failure in mice.

Authors:  Jiajia Lin; Xiaoli Nie; Ying Xiong; Zhangbin Gong; Jiulin Chen; Chuan Chen; Yongyi Huang; Te Liu
Journal:  Am J Transl Res       Date:  2020-01-15       Impact factor: 4.060

4.  Gut microbiota imbalance and its correlations with hormone and inflammatory factors in patients with stage 3/4 endometriosis.

Authors:  Jing Shan; Zhexin Ni; Wen Cheng; Ling Zhou; Dongxia Zhai; Shuai Sun; Chaoqin Yu
Journal:  Arch Gynecol Obstet       Date:  2021-04-11       Impact factor: 2.344

Review 5.  The gut microbiota: a double-edged sword in endometriosis†.

Authors:  Chandni Talwar; Vertika Singh; Ramakrishna Kommagani
Journal:  Biol Reprod       Date:  2022-10-11       Impact factor: 4.161

6.  The colonized microbiota composition in the peritoneal fluid in women with endometriosis.

Authors:  Wen Yuan; Yahong Wu; Xiaoshan Chai; Xianqing Wu
Journal:  Arch Gynecol Obstet       Date:  2022-01-06       Impact factor: 2.344

7.  Network Pharmacology Was Used to Predict the Active Components and Prospective Targets of Paeoniae Radix Alba for Treatment in Endometriosis.

Authors:  Yuting Sun; Junhong Cai; Shun Ding; Shan Bao
Journal:  Reprod Sci       Date:  2022-10-18       Impact factor: 2.924

8.  Associations Between Endometriosis and Gut Microbiota.

Authors:  Agnes Svensson; Louise Brunkwall; Bodil Roth; Marju Orho-Melander; Bodil Ohlsson
Journal:  Reprod Sci       Date:  2021-03-03       Impact factor: 3.060

Review 9.  Intricate Connections between the Microbiota and Endometriosis.

Authors:  Irene Jiang; Paul J Yong; Catherine Allaire; Mohamed A Bedaiwy
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

10.  The Vaginal Microbiome as a Tool to Predict rASRM Stage of Disease in Endometriosis: a Pilot Study.

Authors:  Allison R Perrotta; Giuliano M Borrelli; Carlo O Martins; Esper G Kallas; Sabri S Sanabani; Linda G Griffith; Eric J Alm; Mauricio S Abrao
Journal:  Reprod Sci       Date:  2020-01-06       Impact factor: 2.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.